The FDA is requiring COVID vaccine makers Pfizer and Moderna to update their warnings about the possible risk of myocarditis ...

The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded ...

The Food and Drug Administration is telling Pfizer and Moderna to expand the warning labels on their COVID-19 vaccines about the risk of a possible heart injury side effect linked to the mRNA ...

The FDA has told vaccine manufacturers to expand the warning labels on their COVID-19 shots with more information about the ...

The FDA will require Moderna and Pfizer to add warnings to their COVID-19 vaccine labels about myocarditis and pericarditis in young men.

Panel members had questions about whether a new FDA proposal to require randomized trials for vaccines in healthy adults ...

The FDA is proposing to limit annual COVID-19 boosters to older adults and high-risk individuals. Pfizer and Moderna are requested to update vaccine labels with a warning about potential heart ...

The U.S. Food and Drug Administration will now require COVID-19 vaccines from Pfizer/BioNTech and Moderna to use expanded warning labels with more information about the risk of a rare heart ...

In another sign of growing scrutiny over Covid-19 vaccines ... risk in young men ages 18-24, while Pfizer says the same for young men ages 12-17. The FDA letters asked the companies to expand ...

The Food and Drug Administration is telling Pfizer and Moderna to expand the warning labels on their COVID-19 vaccines about the risk of a possible heart injury side effect linked to the mRNA ...

The U.S. Food and Drug Administration (FDA) has ordered Pfizer and Moderna to expand their warning labels on COVID-19 vaccines. The updated warnings highlight a rare risk of heart inflammation in ...

The warning applies to males ages 16 to 25 and is based on new data from FDA safety monitoring and a 2023 study. This includes both Pfizer's Comirnaty and Moderna's Spikevax vaccines. The updated ...